Next Generation Personalized Neuroblastoma Therapy
Public ClinicalTrials.gov record NCT02780128. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Next Generation Personalized Neuroblastoma Therapy (The NEPENTHE Trial)
Study identification
- NCT ID
- NCT02780128
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Yael P Mosse
- Other
- Enrollment
- 66 participants
Conditions and interventions
Conditions
Interventions
- Biopsy Procedure
- Bone marrow Tests Procedure
- Ceritinib Drug
- ECG Other
- Echocardiogram Other
- Eye Exam Other
- Interviews Behavioral
- Labs Other
- Next Generation Sequencing Genetic
- Physical Exam Other
- Pregnancy Test Other
- Ribociclib Drug
- Tumor Scans Procedure
Procedure · Drug · Other + 2 more
Eligibility (public fields only)
- Age range
- 1 Year to 21 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2016
- Primary completion
- Jul 31, 2022
- Completion
- Jul 31, 2022
- Last update posted
- Mar 9, 2026
2016 – 2022
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02780128, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 9, 2026 · Synced May 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02780128 live on ClinicalTrials.gov.